News
US announces drug treatment for sickle cell anaemia
BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6976.352 (Published 11 February 1995) Cite this as: BMJ 1995;310:352
The first drug treatment for severe sickle cell anaemia has been announced by the National Heart, Lung, and Blood Institute in the US. The drug, hydroxyurea, proved so effective in reducing painful episodes (crises) in adult patients with sickle cell anaemia that a study in 21 centres across the US and Canada of 299 patients with the disease was stopped four months earlier than planned.
The institute issued a two page clinical alert to American doctors last month, saying: “Physicians …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.